A new era of treatment for elderly acute myeloid leukemia (AML) patients?
Hagop M. Kantarjian
Predict response to immune checkpoint inhibition in acute myeloid leukemia (AML) using biomarkers
Naval G. Daver
How do targeted treatments for IDH1 and IDH2 mutations work in acute myeloid leukemia (AML)?
Mohamad Mohty on EBMT 2016
Allogeneic transplant for older AML patients - who, when and how